89. J Natl Cancer Inst. 2018 Jul 1;110(7):696-698. doi: 10.1093/jnci/djy014.Opening the Door for Immune Oncology Studies in Invasive Lobular Breast Cancer.Oesterreich S(1)(2), Lucas PC(3)(4), McAuliffe PF(5), Bruno TC(6)(7), VignaliDAA(7).Author information: (1)Department of Pharmacology and Chemical Biology, Womens Cancer ResearchCenter, UPMC Hillman Cancer Center, Magee Womens Research Institute, Universityof Pittsburgh, Pittsburgh, PA.(2)Section of Breast Surgery, Division of Surgical Oncology, Womens CancerResearch Center, UPMC Hillman Cancer Center, Magee Womens Research Institute,University of Pittsburgh, Pittsburgh, PA.(3)Department of Pathology, University of Pittsburgh School of Medicine,Pittsburgh, PA.(4)NSABP/NRG Oncology, Pittsburgh, PA.(5)Department of Surgery, Womens Cancer Research Center, UPMC Hillman CancerCenter, Magee Womens Research Institute, University of Pittsburgh, Pittsburgh,PA.(6)Department of Immunology (TCB, DAAV), University of Pittsburgh School ofMedicine, Pittsburgh, PA.(7)Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA.DOI: 10.1093/jnci/djy014 PMID: 29471462 